Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
June 03, 2024 08:07 ET
|
Charlesbank Capital Partners LLC
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Four portfolio companies of Charlesbank Capital Partners—Action Behavior Centers, Hearthside Food Solutions, Park Place and Tecomet—have been named to...
InnovAge PACE Recertified as a Great Place to Work
June 03, 2024 08:05 ET
|
InnovAge
InnovAge PACE has been recertified as a Great Place to Work. President and CEO Patrick Blair shares results, accolades, and gratitude.
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
June 03, 2024 08:05 ET
|
NKGen Biotech, Inc.
SANTA ANA, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and...
Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
June 03, 2024 08:04 ET
|
Noom Inc
Noom Launches Noom Vibe, a New Free Wellness Community App
Ready Capital to Present at Nareit’s REITweek 2024
June 03, 2024 08:02 ET
|
Ready Capital Corporation
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Ready Capital Corporation (NYSE:RC) (the “Company”) announced that Tom Capasse, Ready Capital’s Chairman and Chief Executive Officer, will present at...
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
June 03, 2024 08:02 ET
|
Rhythm Pharmaceuticals, Inc.
RYTM CEO at David Meeker at Goldman Sachs Global Healthcare Conference June 10.
Texas Must Close Primary Elections
June 03, 2024 08:01 ET
|
Patriot Mobile Action
Grapevine, TX, June 03, 2024 (GLOBE NEWSWIRE) -- Texas House Speaker Dade Phelan (TX21) has a long history of acting in conflict with his claimed party’s priorities. In February of this year, Phelan...
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
June 03, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual Meeting
June 03, 2024 08:00 ET
|
Medicenna Therapeutics Corp.
Single treatment with bizaxofusp achieved significant survival benefit (mOS of 13.5 vs. 7.2 months, p=0.009) and reduced risk of death by almost half (hazard ratio: 0.54, 95% confidence interval:...
Genesis Offers New Tools and Incentives to Financial Industry Software Developers
June 03, 2024 08:00 ET
|
Genesis Global
Genesis Global announced new technologies and changes in its engagement model to drive broad industry adoption of its application platform.
- June 03, 2024 08:05 ET InnovAge PACE Recertified as a Great Place to Work
- June 03, 2024 08:04 ET Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s